ORIENTBIO, Inc. (002630) Revenue

― Followers

ORIENTBIO, Inc. Revenue

ORIENTBIO, Inc. had a revenue of 6.59B in the quarter ending Jun 30, 2026, with 0.77%. This bring the company's revenue in the last twelve months to 28.66B, Increased -3.66%. In the fiscal year ending Mar 31, 2026, ORIENTBIO, Inc. had annual revenue of 29.75B with 1.21% growth.

Revenue (ttm)

28.66B

Revenue Growth

-3.47%

P/S Ratio

1.64

Revenue/Employee

₩238,035,192

Employees

125

Market Cap

₩48.65B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Mar 31, 2026	29.75B	356.52M	+1.21%
Mar 31, 2025	29.40B	1.39B	+4.97%
Mar 31, 2024	28.01B	-813.90M	-2.82%
Mar 31, 2023	28.82B	2.54B	+9.68%
Mar 31, 2022	26.28B	-25.74B	-49.49%
Mar 31, 2021	52.02B	14.32B	+37.99%
Mar 31, 2020	37.70B	7.33B	+24.12%
Mar 31, 2019	30.37B	-90.83B	-74.94%
Mar 31, 2018	121.21B	―	―